Steroid-Refractory Acute GVHD: Predictors and Outcomes
Patients with steroid-resistant acute graft versus host disease (aGVHD) have a dismal prognosis, with mortality rates in excess of 90%. We sought to identify a subgroup of patients less likely to benefit from initial therapy with corticosteroids as well as the impact of response on day 14 on outcom...
Saved in:
Main Authors: | Jason R. Westin, Rima M. Saliba, Marcos De Lima, Amin Alousi, Chitra Hosing, Muzaffar H. Qazilbash, Issa F. Khouri, Elizabeth J. Shpall, Paolo Anderlini, Gabriela Rondon, Borje S. Andersson, Richard Champlin, Daniel R. Couriel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2011/601953 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Use of Ruxolitinib in an AML Patient with Posttransplant Steroid Refractory GVHD
by: Philip T. Sobash, et al.
Published: (2020-01-01) -
Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model
by: Shinri Sato, et al.
Published: (2025-01-01) -
Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model
by: Shinri Sato, et al.
Published: (2025-02-01) -
The Role of Bacteria and Pattern Recognition Receptors in GvHD
by: E. Holler, et al.
Published: (2010-01-01) -
Intra-mesenteric steroids for steroid-refractory graft-versus-host disease in pediatric patients: A safe option
by: Ana M. Aristizábal, et al.
Published: (2024-12-01)